Acquisition of analgesic properties by the cholecystokinin (CCK)/CCK2 receptor system within the amygdala in a persistent inflammatory pain condition. [electronic resource]
- Pain Feb 2019
- 345-357 p. digital
Publication Type: Journal Article
1872-6623
10.1097/j.pain.0000000000001408 doi
Amygdala--metabolism Animals Cholecystokinin--metabolism Dark Adaptation--drug effects Disease Models, Animal Exploratory Behavior--drug effects Freund's Adjuvant--toxicity Gastrins--therapeutic use Glutamate Decarboxylase--metabolism Inflammation--chemically induced Male Neurons--drug effects Nociception--drug effects Pain--etiology Pain Threshold--drug effects Periaqueductal Gray--drug effects Rats Rats, Sprague-Dawley Receptor, Cholecystokinin B--agonists Signal Transduction--drug effects Sincalide--therapeutic use Tetragastrin--analogs & derivatives